Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Signification of protein p-53 isoforms and immune therapeutic success in chronic lymphocytic leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Oct 2018

Udristioiu Aurelian, Nica-Badea Delia

Abstract excerpt

In the past few years has used thetechnique for analyzing deletions of genes, its rearrangements, cross-reactivity or multiplications in human genome affected of genetic diseases. Was proved that, the best techniques in the investigation of malignant lymphocytes are the Flow Cytometry, Elisa, ICT and Fluorescence in situ hybridization (FISH). Last method, FISH is used as an alternative to chromosomal banding, a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CTLA-4 Antigen

Share to Immunotherapy

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Programmed Cell Death 1 Receptor

Source

Open in PubMed Open full text

Identifiers

PMID: 29945117
DOI: 10.1016/j.biopha.2018.06.072
PMCID: PMC11103075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Signification of protein p-53 isoforms and immune therapeutic success in chronic lymphocytic leukemia.PMID 29945117Read ↗

Assesses of Chronic Lymphocytic Leukemia Cases with Isoform p53 Protein using Elisa MethodSemantic proximity Read ↗

p53 protein expression in chronic lymphocytic leukemia.Semantic proximity Read ↗

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myelomaSemantic proximity Read ↗

Identification of molecular and functional patterns of p53 alterations in chronic lymphocytic leukemia patients in different phases of the disease.Semantic proximity Read ↗

Evaluation of TP53 Expression and Mutations among Hematological Malignancies Patients in Saudi ArabiaSemantic proximity Read ↗

TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors.Semantic proximity Read ↗

TP53 aberrations in chronic lymphocytic leukemia.Semantic proximity Read ↗

Frequency Of TP53 Gene Mutation In Patients With Chronic Lymphocytic Leukaemia.Semantic proximity Read ↗

Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.Semantic proximity Read ↗

Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.Semantic proximity Read ↗

Genetic alterations in chronic lymphocytic leukaemia.Semantic proximity Read ↗

[Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.